Hot penny stocks... don't get burned
   

Profile for Repligen Cp (RGEN)

Markets Quote Depth/LII Options Charts News Profile Financials Insiders Filings Analyst Earnings Historical
Symbol: powered by
  quotemedia.com
Profile for Repligen Corp.  (RGEN) 
$ 5.35      -0.07 (-1.29%) Volume: 107.24 k 4:00 PM EDT Aug 21, 2008
Business Description:
A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system.
Address:    41 Seyon Street, Building #1, Suite 100, Waltham, MA 02453
Telephone:   
(781) 250-0111
 
Website:   
www.repligen.com
Facsimile:   
(781) 250-0115
Email:   
investors@repligen.com
Details
CEO:   
Dr. Walter C. Herlihy, Ph.D.
Employees:   
56
Market Cap:   
166.77 m
Issue Type:   
Common Stock
Auditor:    Ernst & Young LLP
Last Audit:    Unqualified
Indices:    Russell 2000
Industry Classifications
Sector:   
Healthcare
CIK:   
0000730272
Industry:    Drugs
NAICS:    Biological Product (except Diagnostic) Manufacturing (325414)
QM ID:    Biotechnology (515)
SIC:    Biological Products, Except Diagnostic Substances (2836) , Commercial Physical And Biological Research (8731)
Profitability
Management Effectiveness
Gross Margin:   
72.30
Return on Equity:   
57.90
EBIT Margin:   
 
Return on Capital:   
57.90
Profit Margin:   
 
Return on Assets:   
53.90
Share Statistics
Outstanding:   
31.17 m
Float:   
28.11 m
Short Interest:   
2.47 m (as of 7/28/08)
Short Int Ratio:   
22.90
% of Float:   
8.80%
Non-Corp. Insider Hold'gs:   
9.80% (as of 6/1/08)
Bought Prev 3 Mo:   
0
Sold Prev 3 Mo:   
0
Institution Hold'gs:   
47.80% (as of 7/1/08)
Total Held:   
14.9 m
Institutions:   
74
Bought Prev Mo:   
2.66 m
Sold Prev Mo:   
1.17 m

Copyright © QuoteMedia.   Data delayed at least 15 min. unless otherwise indicated.   RT   Realtime,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMedia, profiles by Hemscott.  Terms of Use. 
   
Research Report
Hotstocked.com has a complete research report available for RGEN stock. Download RGEN report.
Research Report
Get the full report for FREE
Date:May 14, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download RGEN report
  
Example preview: Research report for Repligen Cp (RGEN) Research report for Repligen Cp (RGEN) Research report for Repligen Cp (RGEN) Research report for Repligen Cp (RGEN)
   
   
   
   
   
Summary
Research Report
Description
Level 2 quotes
Charts
News
Profile
Balance Sheet
Income Statement
Cash Flow Statement
Insiders
SEC Filings
Analyst Recommendation
Earnings Report
Historical Prices
Recent Material Events
Key executives
Comments
   
   
   
   

SPKL shot up 26%


From: OTC Journal
Added: 22 Sep, 2007

   

Add to Google
Add to My Yahoo!
rss
 
 
Home > Companies > Repligen Cp
Home | Message boards | Newsletters | Latest Comments | VC directory | AIM London Stock Exchange | Canadian stocks | Chinese stocks | Broker Directory
About us | Privacy Policy | Disclaimer | Compensation Disclosure | Contributors | Contact form
© 2007 - 2008 hotstocked.com - All rights reserved.